You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • PO.3.67 Measuring IFNA2 levels by a single-molecule array in clinical practice of childhood-onset sle patients does matter; results from a single center longitudinal study

Article info

Article menu

Download PDFPDF

Thursday 06 October 2022 from 13:00 to 14:10
Po.3 E- poster session 3: cardiovascular manifestations, cytokines and complement system in SLE, difficult cases, organ damage and survival, innate immunity
PO.3.67 Measuring IFNA2 levels by a single-molecule array in clinical practice of childhood-onset sle patients does matter; results from a single center longitudinal study

Authors

  • Marleen Verkaaik Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles
  • Wahadat M Javad Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles
  • Hongchao Qi Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles
  • Cornelia G van Helden-Meeuwsen Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles
  • Erika Huijser Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles
  • Lotte van den Berg Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles
  • Jens Göpfert Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles
  • Marleen Verkaaik Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles
  • Marco Schreurs Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles
  • Sylvia Kamphuis Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles
  • Marjan A Versnel Dept. Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands, Dept. Paediatric Rheumatology, Sophia Children’s hospital, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands, NMI Natural and Medical Sciences Institute at the University of Tübingen, Dep. of Applied, Biomarkers and Immunoassays, Reutlingen, Germany PubMed articlesGoogle scholar articles

Citation

Verkaaik M, Javad WM, Qi H, et al
PO.3.67 Measuring IFNA2 levels by a single-molecule array in clinical practice of childhood-onset sle patients does matter; results from a single center longitudinal study
Lupus Science & Medicine 2022;9:doi: 10.1136/lupus-2022-elm2022.96

Publication history

  • First published September 27, 2022.
Online issue publication 
October 13, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.